Palliative care in oncology: changing perceptions, improving care

Why is palliative care still so often seen as a last resort and what would it take to change that? In this episode of TJ Talks, Professors Claudia Gamondi (Head of the Palliative and Supportive Care service at Lausanne University Hospital, and Tumori Journal Section Editor) and Claudia Bausewein (…

Interdisciplinary Innovations in Epigenetics and CAR-T Cell Therapy

Real breakthroughs happen when the research brings together different skills, knowledge and passion. Discover an inspiring perspective on interdisciplinary approaches to CAR-T cell therapies in this episode of TJ Talks, which guests Professor Yael David, Head of the laboratory and associate member …

Early Diagnosis as a Determinant of Childhood Cancer Survival: Insights from the BENCHISTA Project

The BENCHISTA – International  Benchmarking of Childhood Cancer Survival by Tumor stage – project is a worldwide collaboration led by University College London (UCL)  and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) aiming to better understand the reasons behind international diffe…

Advanced Ovarian Cancer: Shaping Future Treatment Strategies

What emerges from the most recent first line trials is that the progress in advanced ovarian cancer depends not only on new treatment, but on the better patient selection: not all patients are in the same situation. And the most appropriate treatment must be determined for each individual: the best…

Outcomes that Matter: a Common Sense Revolution in Oncology

Caught between enthusiasm for technical innovation and the need for a critical assessment of research practices, the oncology is seeking a new path that offers real hope for effective treatments and a fair distribution of resources for the benefit of patients, because, as Prof. Gyawali’s elderly pa…

Integrare razionalità clinica e responsabilità sistemica: il Common Sense Oncology in Italia

Imparare a governare l'innovazione: questo l'invito che il cosiddetto Common Sense Oncology rivolge alla comunità oncologica per un approccio terapeutico interamente centrato sui bisogni del paziente. Alla base del ragionamento c'è una domanda semplice: siamo sicuri che più trattamento significhi s…

Tackling the clinical challenges of GU Oncology

From advances in the screening of prostate cancer to the management of the genitourinary tumors, the GU oncology addresses ever more clinical challenges.  What are the most relevant challenges in the management of the prostate cancer population? "It is crucial to balance the right treatment strate…

Primary and Surrogate Endpoints in Clinical Trials: Implementation and Challenges in Daily Practice

The choice of an endpoint can really change the way a treatment is administered or approved for use on patients. And in the future, we will see much more data on quality of life, and trials will probably also work on validating surrogate endpoints and biomarkers.  In this TJ Talks dedicated to the…

Pharmaco-prevention in Breast Cancer: a strategy to halve the incidence of a potentially fatal disease

Pharmaco-prevention of breast cancer is an evidence-based strategy that uses drugs to reduce the risk of disease in high-risk women. However, the use of this strategy remains modest due to concerns about toxicity, low awareness and difficulties in patient selection. In this TJ Talks podcast, toget…

The last journey: the invisible needs of migrant patients between palliative care and the need for protection

Stories of foreign cancer patients who ask to return to their country at the end of their lives: their deep desire to see their loved ones one last time is intertwined with medical, legal and financial issues that seem insurmountable. In this TJ Talks, Dr Sergio Defendi, director of Palliative Care…